CAMP4 Therapeutics Corporation (CAMP) vs InflaRx N.V. (IFRX)
A side-by-side comparison of CAMP4 Therapeutics Corporation and InflaRx N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IFRX
InflaRx N.V.
$1.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CAMP vs IFRX
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)IFRX +13.5% (+6.5%/yr)IFRX compounded faster over this window
CAMP IFRX
CAMP vs IFRX: by the numbers
- •CAMP is the larger company ($249M vs $233M market cap).
- •Both run net losses; CAMP's is the smaller (-2543.74% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | CAMP | IFRX |
|---|---|---|
| P/S ratio | 58.94 | N/A |
| P/B ratio | N/A | 1.39 |
Profitability
| Metric | CAMP | IFRX |
|---|---|---|
| Gross margin | 53.14% | -24677.94% |
| Operating margin | -1488.31% | -164525.50% |
| Net margin | -2543.74% | -155582.08% |
| ROE | N/A | -27.27% |
| ROIC | -69.76% | -25.38% |
Growth (annualized)
| Metric | CAMP | IFRX |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
| Total return CAGR (5Y) | N/A | -7.34% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.